Synthomer Dividends - SYNT

Synthomer Dividends - SYNT

Buy
Sell
Best deals to access real time data!
Level 2 Basic
Monthly Subscription
for only
£62.08
Silver
Monthly Subscription
for only
£17.37
UK/US Silver
Monthly Subscription
for only
£30.59
VAT not included
Stock Name Stock Symbol Market Stock Type Stock ISIN Stock Description
Synthomer Plc SYNT London Ordinary Share GB0009887422 ORD 10P
  Price Change Price Change % Stock Price Last Trade
-2.60 -0.61% 425.00 12:17:14
Open Price Low Price High Price Close Price Previous Close
430.00 423.00 430.00 427.60
more quote information »
Industry Sector
CHEMICALS

Synthomer SYNT Dividends History

Announcement Date Type Currency Dividend Amount Period Start Period End Ex Date Record Date Payment Date Total Dividend Amount
06/08/2019InterimGBX431/12/201831/12/201903/10/201904/10/201905/11/20194
04/03/2019FinalGBX9.131/12/201731/12/201806/06/201907/06/201905/07/201913.1
06/08/2018InterimGBX431/12/201731/12/201804/10/201805/10/201806/11/20180
01/03/2018FinalGBX8.531/12/201631/12/201707/06/201808/06/201806/07/201812.2
08/08/2017InterimGBX3.731/12/201631/12/201705/10/201706/10/201706/11/20170
06/03/2017FinalGBX7.831/12/201531/12/201608/06/201709/06/201706/07/201711.3
09/08/2016InterimGBX3.531/12/201531/12/201606/10/201607/10/201604/11/20160
02/03/2016FinalGBX5.431/12/201431/12/201502/06/201603/06/201604/07/20168.6
11/08/2015InterimGBX3.231/12/201431/12/201508/10/201509/10/201505/11/20150
26/02/2015FinalGBX4.831/12/201331/12/201404/06/201505/06/201503/07/201515.6
26/02/2015SpecialGBX7.831/12/201331/12/201404/06/201505/06/201503/07/20150
11/08/2014InterimGBX331/12/201331/12/201408/10/201410/10/201406/11/20140
28/02/2014FinalGBX3.631/12/201231/12/201304/06/201406/06/201404/07/20146
13/08/2013InterimGBX2.431/12/201231/12/201309/10/201311/10/201307/11/20130
15/03/2013FinalGBX3.331/12/201131/12/201205/06/201307/06/201305/07/20135.5
28/08/2012InterimGBX2.231/12/201131/12/201210/10/201212/10/201208/11/20120

Top Dividend Posts

DateSubject
21/10/2020
09:35
philanderer: xd tomorrow morning for the 3p dividend
14/10/2020
07:23
robow: FY2020 EBITDA guidance raised 10%, interim dividend reinstated and pro forma leverage expected to reduce to circa 2.0x EBITDA by end of 2020
06/8/2020
09:34
philanderer: Good news :-) '..Board expects to pay a full year 2020 dividend.'
15/1/2020
15:18
scooper72: Are u not tempted to hold on for the decent dividend?
19/12/2019
18:15
philanderer: SYNT about the only one of mine that moved today... 450k traded
25/10/2019
11:34
scooper72: My SIPP was already in the red on these but had just bought some for my ISA and they seemed to be doing ok but now those are minus seven percent. Will probably keep both holdings long term as it looks like a good business going forward over the next 10 years and at least there is the dividend which seems well covered and which has been growing over the years.
03/10/2019
11:10
philanderer: Looks like the warning on polyolefin from ZTF ... common to SYNT.
15/9/2019
08:21
robow: GREAT IDEAS 10 | SHARES | 12 September 2019 Chemicals firm Synthomer (SYNT) looks very tempting at the current price following a big sell-off over the past year. The firm’s share price dropped from around 530p a year ago to 280p last month and saw the stock trade on nearly its lowest rating in a decade, while its level of debt compared to how much it’s earning is expected to double. But with the business on the cusp of global expansion as it aims to keep up with soaring demand for its products, investors with a long-term view may want to take advantage of the firm’s cheap valuation. The chemicals sector has historically been a good place to invest with significant share price gains over the past decade and occasionally generous dividends. But chemicals companies have been caught up by concerns over a global economic slowdown in the past year, and some in the market think this may feed into weaker demand for chemicals products. Synthomer has tried to expand significantly to keep up with demand for its speciality products, sought after due to many factors such as urbanisation, ageing demographics and stricter legislation. The firm supplies aqueous polymers to companies, which The company should benefit from capacity expansion and a deal to boost its position in the US and Europe The outlook is looking brighter for Synthomer Synthomer is also forecast by analysts at Canaccord and Numis to have a much stronger second half of this year as market conditions are set to improve. That combined with its completed upgrades to facilities in Germany and Malaysia means the firm will have greater capacity to meet demand for its products. Its net debt-to-earnings ratio is expected to increase next year to between 2.2 and 3-times as the Omnova deal is completed. But Synthomer has a clear plan to get this down below 2-times by the end of 2021. Its management team has a disciplined approach to M&A, with a ‘conservative capital’ policy meaning it’s unlikely to ever be reckless in the pursuit of growth. help create new products and boost the performance of existing ones, such as footwear insoles, condoms, packaging tapes, carpets and waterproofing products. While strong on the consumer side, investors had questioned Synthomer’s growth prospects given its lack of real penetration into the industrial market. But the proposed deal to acquire Omnova Solutions, an American speciality chemicals business operating in sectors like construction and oil and gas, could make the market reappraise Synthomer. As well as the US, Omnova has manufacturing and technical facilities in Europe, Thailand and China. Analysts at UBS believe the acquisition will help Synthomer sell more products in the US, and help it expand its facilities in Europe. SYNT is also forecast by analysts at Canaccord and Numis to have a much stronger second half of this year as market conditions are set to improve. That combined with its completed upgrades to facilities in Germany and Malaysia means the firm will have greater capacity to meet demand for its products. Its net debt-to-earnings ratio is expected to increase next year to between 2.2 and 3-times as the Omnova deal is completed. But Synthomer has a clear plan to get this down below 2-times by the end of 2021. Its management team has a disciplined approach to M&A, with a ‘conservative capital’ policy meaning it’s unlikely to ever be reckless in the pursuit of growth. help create new products
07/8/2018
18:25
johnsoho: RNS looks good to me and there is an increased dividend; I’m adding to my holding Synthomer PLC Results for the six months ended 30 June 2018 Intraday Synthomer Chart Intraday Synthomer Chart 06/08/2018 7:00am UK Regulatory (RNS & others) TIDMSYNT RNS Number : 8856W Synthomer PLC 06 August 2018 6 August 2018 Synthomer plc Interim Results for the six months ended 30 June 2018 Geographic & product diversity underpins sustainable growth Underlying profit before tax up 6.4% and full year expectations unchanged H1 HIGHLIGHTS 2018 2017 Increase / (decrease) Underlying performance (1) Reported Constant Currency(2) ------- ------- --------- ------------- GBPm GBPm % % Revenue 833.8 770.3 8.2 6.4 ------- ------- --------- Volumes (ktes) 796.6 730.2 9.1 9.1 ------- ------- --------- Europe and North America 64.4 64.3 0.2 (1.4) (ENA) Asia and ROW (ARW) 22.5 18.1 24.3 21.5 Unallocated (7.5) (5.9) (27.1) (27.1) ------- ------- --------- Operating Profit 79.4 76.5 3.8 1.8 ------- ------- --------- Profit before Tax 76.2 71.6 6.4 4.3 ------- ------- --------- EPS (p) 18.4 16.8 9.5 DPS (p) 4.0 3.7 8.1 IFRS Profit before Tax 86.2 53.4 61.4 IFRS EPS (p) 20.6 12.5 64.8 -------------------------------------- ------- ------- --- --------- ------------- 1 - Underlying performance excludes Special Items. Comments on Underlying performance and a detailed analysis of the Special Items are set out in note 3. 2 - Constant currency sales and profit: these reflect current year results for the Existing business translated at the prior year's average exchange rates, and include the impact of acquisitions. H1 highlights: -- Underlying profit before tax (PBT) up 6.4% to GBP76.2m (constant currency up 4.3%): -- Good volume growth in Europe & North America (ENA); unit margins slightly softer due to US$ transaction headwind (c.GBP5m) -- Strong volume growth in Asia & Rest of World (ARW); unit margin growth in Nitriles -- Successful integration of BASF Pischelsdorf following completion in January -- IFRS profit before tax GBP86.2m -- Investment programme to increase capacity across the network on track -- R&D delivering sustainable growth: new products represent circa 20% of total sales in Existing business (2017: 20%) -- Effective tax rate reduced to 18.0% (H1 2017: 20.0%) -- Underlying earnings per share up 9.5% at 18.4p per share -- Interim dividend of 4.0p (2017: 3.7p); increase of 8.1% in line with dividend policy -- Strong and flexible balance sheet maintained - leverage 1.1x EBITDA Commenting on the results, Neil Johnson, Chairman, said: "Synthomer has had a good first six months of the year, reporting a further increase in Underlying profit, underpinned by our geographic and product diversity alongside the Group's strategy of driving organic growth and investing in bolt-on acquisitions. We have made strong operational progress, with continued progress on Safety, Health & Environment policies as well as the Manufacturing Excellence initiatives delivering improved efficiency and output. Our investment programme to increase production capacity has continued. We have also invested to strengthen our supply chain resilience and procurement flexibility in a relatively volatile raw material market. Inorganic growth has come through our acquisition of the Pischelsdorf site from BASF during January. Notwithstanding ongoing political and economic uncertainty, the Group's diversified business means we are well placed to make continued progress and the Board's expectations for the full year remain unchanged. Looking to 2019, we remain cautiously optimistic about the future prospects of the Group. The growth capex is expected to yield returns in both ENA and ARW and we will continue to explore both bolt-on and transformational acquisitions in a disciplined manner.
07/8/2018
18:23
johnsoho: Nice RNS with an increased dividend. Synthomer PLC Results for the six months ended 30 June 2018 Intraday Synthomer Chart Intraday Synthomer Chart 06/08/2018 7:00am UK Regulatory (RNS & others) TIDMSYNT RNS Number : 8856W Synthomer PLC 06 August 2018 6 August 2018 Synthomer plc Interim Results for the six months ended 30 June 2018 Geographic & product diversity underpins sustainable growth Underlying profit before tax up 6.4% and full year expectations unchanged H1 HIGHLIGHTS 2018 2017 Increase / (decrease) Underlying performance (1) Reported Constant Currency(2) ------- ------- --------- ------------- GBPm GBPm % % Revenue 833.8 770.3 8.2 6.4 ------- ------- --------- Volumes (ktes) 796.6 730.2 9.1 9.1 ------- ------- --------- Europe and North America 64.4 64.3 0.2 (1.4) (ENA) Asia and ROW (ARW) 22.5 18.1 24.3 21.5 Unallocated (7.5) (5.9) (27.1) (27.1) ------- ------- --------- Operating Profit 79.4 76.5 3.8 1.8 ------- ------- --------- Profit before Tax 76.2 71.6 6.4 4.3 ------- ------- --------- EPS (p) 18.4 16.8 9.5 DPS (p) 4.0 3.7 8.1 IFRS Profit before Tax 86.2 53.4 61.4 IFRS EPS (p) 20.6 12.5 64.8 -------------------------------------- ------- ------- --- --------- ------------- 1 - Underlying performance excludes Special Items. Comments on Underlying performance and a detailed analysis of the Special Items are set out in note 3. 2 - Constant currency sales and profit: these reflect current year results for the Existing business translated at the prior year's average exchange rates, and include the impact of acquisitions. H1 highlights: -- Underlying profit before tax (PBT) up 6.4% to GBP76.2m (constant currency up 4.3%): -- Good volume growth in Europe & North America (ENA); unit margins slightly softer due to US$ transaction headwind (c.GBP5m) -- Strong volume growth in Asia & Rest of World (ARW); unit margin growth in Nitriles -- Successful integration of BASF Pischelsdorf following completion in January -- IFRS profit before tax GBP86.2m -- Investment programme to increase capacity across the network on track -- R&D delivering sustainable growth: new products represent circa 20% of total sales in Existing business (2017: 20%) -- Effective tax rate reduced to 18.0% (H1 2017: 20.0%) -- Underlying earnings per share up 9.5% at 18.4p per share -- Interim dividend of 4.0p (2017: 3.7p); increase of 8.1% in line with dividend policy -- Strong and flexible balance sheet maintained - leverage 1.1x EBITDA Commenting on the results, Neil Johnson, Chairman, said: "Synthomer has had a good first six months of the year, reporting a further increase in Underlying profit, underpinned by our geographic and product diversity alongside the Group's strategy of driving organic growth and investing in bolt-on acquisitions. We have made strong operational progress, with continued progress on Safety, Health & Environment policies as well as the Manufacturing Excellence initiatives delivering improved efficiency and output. Our investment programme to increase production capacity has continued. We have also invested to strengthen our supply chain resilience and procurement flexibility in a relatively volatile raw material market. Inorganic growth has come through our acquisition of the Pischelsdorf site from BASF during January. Notwithstanding ongoing political and economic uncertainty, the Group's diversified business means we are well placed to make continued progress and the Board's expectations for the full year remain unchanged. Looking to 2019, we remain cautiously optimistic about the future prospects of the Group. The growth capex is expected to yield returns in both ENA and ARW and we will continue to explore both bolt-on and transformational acquisitions in a disciplined manner.
ADVFN Advertorial
Your Recent History
LSE
SYNT
Synthomer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201203 12:34:27